Evaluating Remote Ischemic Conditioning to Improve Outcomes for Adults Undergoing Off-pump Coronary Artery Bypass Surgery in China
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2024-07-12
648
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effects of remote ischemic conditioning RIC in patients with coronary artery disease who are scheduled for off-pump coronary artery bypass grafting CABG. This national, multi-center, randomized controlled trial in China aims to determine whether RIC can improve the short-term prognosis by reducing ischemia-reperfusion injury during and after surgery. The study will enroll 648 patients to compare outcomes between those receiving RIC and those in a control group.
In the trial, patients will be randomly assigned to either the RIC group or the control group. The RIC group will undergo a treatment involving automatic blood pressure cuffs placed on both upper arms, applying cycles of high pressure for 5 minutes followed by 5 minutes of rest, repeated four times each session. This conditioning occurs for three days before and seven days after the CABG surgery. The control group will have the cuffs placed similarly but inflated only to a low pressure of 60 mmHg without therapeutic effect.
Participants will be closely monitored for major adverse cardiovascular and cerebrovascular events MACCE within three months after enrollment, including death, heart attacks, strokes, and additional heart surgeries. Secondary outcomes include length of stay in intensive care and hospital, as well as physical function measured by a 6-minute walk test. Assessments will include cardiac ultrasound and clinical evaluations during hospital stay and follow-up visits. The total study participation period covers several months post-surgery to track recovery and safety outcomes.
CONDITIONS
Brief Title
Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting
Research Team
Y
Yang Yan
L
Li Guoliang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
First Affiliated Hospital Xi'an Jiaotong University
Lead Sponsor
Beijing Anzhen Hospital
Collaborating Sponsor
Who Can Participate
Age: 18Years - 70Years
All Genders
Eligibility Criteria
You may qualify if you...
Diagnosed with coronary artery disease and require off-pump CABG surgery.
Between 18 and 75 years old.
Normal left ventricular systolic function with ejection fraction greater than 40%.
Left ventricular end-diastolic internal diameter less than 60 mm.
No or mild heart valve and great vessel abnormalities that do not need surgery.
Participant or authorized relative agrees to participate and signs informed consent.
You will not qualify if you...
Severe tissue injuries.
Myalgia, fractures, or other peripheral vascular lesions.
Use of radial artery as bypass graft.
Stenosis or severe malformations of subclavian, jugular, or femoral arteries and veins.
Previous vagus nerve trunk dissection or vagus nerve block surgery.
Undergoing other surgical operations at the same time.
Severe cardiac insufficiency, acute coronary syndromes, malignant hypertension, or cardiogenic shock.
Severe coagulation abnormalities or severe anemia.
Severe mental disorder.
Malignant tumors.
Pregnant or lactating women.
Increased risk of treatment per investigator judgment.
Refusal to sign informed consent form.
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - 10 days
Participants undergo off-pump coronary artery bypass grafting surgery with remote ischemic conditioning or control procedure applied before and after surgery.
Daily visits during 3 days before and 7 days after surgery
Follow-up
Duration - 3 months
Participants are monitored for safety and efficacy outcomes including major adverse cardiovascular and cerebrovascular events.
Periodic assessments up to 3 months after enrollment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Evaluating Avoiding Graft Recooling After Normothermic Machine Perfusion in Liver Transplantation A Multicenter Randomized Trial
Comparing Non-Invasive CCTA and Invasive CAG for Planning Coronary Artery Bypass Surgery in Patients with Blocked Heart Arteries
Randomized Study Comparing Single and Multiple Arterial Grafts in Women Undergoing Coronary Artery Bypass Surgery
Comparing Desflurane and Propofol Anesthesia to Reduce Major Heart Problems After Coronary Artery Bypass Surgery
Observational Study of Blood Markers and Recovery in Women Undergoing DIEP Flap Breast Reconstruction After Breast Cancer Surgery
Study on Frailty and Outcomes in Older Adults Undergoing Treatment for Coronary Artery Disease
Comparing Pregabalin and Dexmedetomidine for Treating Delirium After Coronary Artery Bypass Surgery in Older Adults
Study of Remimazolam Use During Coronary Artery Bypass Surgery to Prevent Postoperative Atrial Fibrillation
Remote Ischemic Conditioning as a Treatment for Mild to Moderate Non-Proliferative Diabetic Retinopathy in Adults With Type 2 Diabetes
Evaluating Safety and Effectiveness of No-touch Technique in Minimally Invasive Coronary Artery Bypass Surgery Compared to Conventional Off-Pump Surgery
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Rationale and Design of the IMPROVE Trial: A Multicenter, Randomized, Controlled, Open-label, Blinded-endpoint Trial Assessing the Efficacy of Remote Ischemic Conditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting.